The AR industry is growing at a remarkable rate and is influencing a number of industries. The pharma industry has been quick to adopt this exciting technology in the following notable ways.
Augmented reality has been adopted by a myriad of industries, including education, gaming and, of course, healthcare. It is due to this pervasiveness that the AR and VR markets are expected to reach $768 billion by 2025.
At Random42, we create scientific Augmented Reality (AR) apps that use visual recognition technology. Using our apps, users simply point their smart device at a tracker, activating an interactive experience involving animations, holograms, 3D models and even gaming aspects. More recently, AR ‘markerless’ experiences have been developed, which use surface recognition technology to anchor the interactive content to any flat surface like a table or the floor.
Using AR, we are able to bring marketing materials to life, demonstrate pharmaceutical MOAs (Mechanisms of Action) and create tools for routing R&D facilities. The use of AR is growing by the day and we’re excited to see how we’ll utilize it in the future.
Below, we explore three major ways augmented reality is being used in the pharmaceutical industry.